Bone regeneration for murine femur fracture by gelatin hydrogels incorporating basic fibroblast growth factor with different release profiles

Tissue Engineering - Part A

Volumn 20, Issue 9-10, 2014, Pages 1531-1541

  Furuya, Hiroyuki ^a,b   Tabata, Yasuhiko ^a   Kaneko, Kazuo ^b  

^a KYOTO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CROSSLINKING; FRACTURE; WATER CONTENT;

BASIC FIBROBLAST GROWTH FACTOR; BIODEGRADABLE HYDROGELS; BONE REGENERATION; DIFFERENT WATER CONTENTS; GELATIN HYDROGELS; GLUTARALDEHYDE CROSS-LINKING; ISO-ELECTRIC POINTS; REACTION CONDITIONS;

HYDROGELS;

FIBROBLAST GROWTH FACTOR 2; GELATIN; MESSENGER RNA; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2; DRUG IMPLANT; HYDROGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERALIZATION; BONE REGENERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FEMUR FRACTURE; HISTOPATHOLOGY; HYDROGEL; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; REAL TIME POLYMERASE CHAIN REACTION; WATER CONTENT; ADMINISTRATION AND DOSAGE; ANIMAL; BIODEGRADABLE IMPLANT; C57BL MOUSE; CHEMISTRY; DIFFUSION; DOSE RESPONSE; DRUG EFFECTS; DRUG IMPLANT; FEMORAL FRACTURES; FRACTURE HEALING; MALE; MATERIALS TESTING; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; ANIMALS; BONE REGENERATION; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; FEMORAL FRACTURES; FIBROBLAST GROWTH FACTOR 2; FRACTURE HEALING; GELATIN; HYDROGELS; MALE; MATERIALS TESTING; MICE; MICE, INBRED C57BL; TREATMENT OUTCOME;

EID: 84899835650     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0763     Document Type: Article

References (73)

1. Nakajima, F., Nakajima, A., Ogasawara, A., Moriya, H., and Yamazaki, M. Effects of a single percutaneous injection of basic fibroblast growth factor on the healing of a closed femoral shaft fracture in the rat. Calcif Tissue Int 81, 132, 2007.
2. Gospodarowicz, D., Ferrara, N., Schweigerer, L., and Neufeld, G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8, 95, 1987.
3. Rifkin, D.B., and Moscatelli, D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109, 1, 1989.
4. Globus, R.K., Plouet, J., and Gospodarowicz, D. Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 124, 1539, 1989.
5. Rodan, S.B., Wesolowski, G., Thomas, K.A., Yoon, K., and Rodan, G.A. Effects of acidic and basic fibroblast growth factors on osteoblastic cells. Connect Tissue Res 20, 283, 1989.
6. Cuevas, P., Burgos, J., and Baird, A. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem Biophys Res Commun 156, 611, 1988.
7. Froger-Gaillard, B., Charrier, A.M., Thenet, S., Ronot, X., and Adolphe, M. Growth-promoting effects of acidic and basic fibroblast growth factor on rabbit articular chondrocytes aging in culture. Exp Cell Res 183, 388, 1989.
8. Canalis, E., Centrella, M., and McCarthy, T. Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 81, 1572, 1988.
9. Kawaguchi, H., Kurokawa, T., Hanada, K., Hiyama, Y., Tamura, M., Ogata, E., et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135, 774, 1994.
10. Nakamura, T., Hanada, K., Tamura, M., Shibanushi, T., Nigi, H., Tagawa, M., et al. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136, 1276, 1995.
11. Schliephake, H., Neukam, F.W., Lohr, A., and Hutmacher, D. The use of basic fibroblast growth factor (bFGF) for enhancement of bone ingrowth into pyrolized bovine bone. Int J Oral Maxillofac Surg 24, 181, 1995.
12. Wang, J.S. Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants. Acta Orthop Scand Suppl 269, 1, 1996.
13. Yamada, K., Tabata, Y., Yamamoto, K., Miyamoto, S., Nagata, I., Kikuchi, H., et al. Potential efficacy of basic fibroblast growth factor incorporated in biodegradable hydrogels for skull bone regeneration. J Neurosurg 86, 871, 1997.
14. Tabata, Y., Yamada, K., Miyamoto, S., Nagata, I., Kikuchi, H., Aoyama, I., et al. Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 19, 807, 1998.
15. Aebischer, P., Salessiotis, A.N., and Winn, S.R. Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps. J Neurosci Res 23, 282, 1989.
16. Laquerriere, A., Peulve, P., Jin, O., Tiollier, J., Tardy, M., Vaudry, H., et al. Effect of basic fibroblast growth factor and alpha-melanocytic stimulating hormone on nerve regeneration through a collagen channel. Microsurgery 15, 203, 1994.
17. Ide, C., Tohyama, K., Tajima, K., Endoh, K., Sano, K., Tamura, M., et al. Long acellular nerve transplants for allogeneic grafting and the effects of basic fibroblast growth factor on the growth of regenerating axons in dogs: a preliminary report. Exp Neurol 154, 99, 1998.
18. Thompson, J.A., Anderson, K.D., DiPietro, J.M., Zwiebel, J.A., Zametta, M., Anderson, W.F., et al. Site-directed neovessel formation in vivo. Science 241, 1349, 1988.
19. Rosenblum, S.F., Frenkel, S., Ricci, J.R., and Alexander, H. Diffusion of fibroblast growth factor from a plaster of Paris carrier. J Appl Biomater 4, 67, 1993.
20. DeBlois, C., Cote, M.F., and Doillon, C.J. Heparin-fibroblast growth factor-fibrin complex: in vitro and in vivo applications to collagen-based materials. Biomaterials 15, 665, 1994.
21. Yamamura, K., Sakurai, T., Yano, K., Nabeshima, T., and Yotsuyanagi, T. Sustained release of basic fibroblast growth factor from the synthetic vascular prosthesis using hydroxypropylchitosan acetate. J Biomed Mater Res 29, 203, 1995.
22. Tabata, Y., Nagano, A., and Ikada, Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5, 127, 1999.
23. Plank, J., and Rychlo, A. [A method for quick decalcification]. Zentralbl Allg Pathol 89, 252, 1952.
24. Kimura, Y., and Tabata, Y. Controlled release of stromalcell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed 21, 37, 2010.
25. Ozeki, M., and Tabata, Y. In vivo degradability of hydrogels prepared from different gelatins by various crosslinking methods. J Biomater Sci Polym Ed 16, 549, 2005.
26. Holstein, J.H., Menger, M.D., Culemann, U., Meier, C., and Pohlemann, T. Development of a locking femur nail for mice. J Biomech 40, 215, 2007.
27. Gospodarowicz, D. Fibroblast growth factor. Chemical structure and biologic function. Clin Orthop Relat Res 257, 231, 1990.
28. Weiss, A.P., Olmedo, M.L., Lin, J.C., and Ballock, R.T. Growth factor modulation of the formation of a molded vascularized bone graft in vivo. J Hand SurgAm20, 94, 1995.
29. Berrada, S., Lefebvre, F., and Harmand, M.F. The effect of recombinant human basic fibroblast growth factor rhFGF-2 on human osteoblast in growth and phenotype expression. In Vitro Cell Dev Biol Anim 31, 698, 1995.
30. Hanada, K., Dennis, J.E., and Caplan, A.I. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 12, 1606, 1997.
31. Pri-Chen, S., Pitaru, S., Lokiec, F., and Savion, N. Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 23, 111, 1998.
32. Amizuka, N., Yamada, M., Watanabe, J.I., Hoshi, K., Fukushi, M., Oda, K., et al. Morphological examination of bone synthesis via direct administration of basic fibroblast growth factor into rat bone marrow. Microsc Res Tech 41, 313, 1998.
33. Mayahara, H., Ito, T., Nagai, H., Miyajima, H., Tsukuda, R., Taketomi, S., et al. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9, 73, 1993.
34. Simmons, C.A., Alsberg, E., Hsiong, S., Kim, W.J., and Mooney, D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35, 562, 2004.
35. Kawai, K., Suzuki, S., Tabata, Y., Ikada, Y., and Nishimura, Y. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 21, 489, 2000.
36. Ikada, Y., and Tabata, Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 31, 287, 1998.
37. Inoue, A., Takahashi, K.A., Arai, Y., Tonomura, H., Sakao, K., Saito, M., et al. The therapeutic effects of basic fibroblast growth factor contained in gelatin hydrogel microspheres on experimental osteoarthritis in the rabbit knee. Arthritis Rheum 54, 264, 2006.
38. Jackson, R.A., Nurcombe, V., and Cool, S.M. Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 379, 79, 2006.
39. Schofer, M.D., Fuchs-Winkelmann, S., Grabedunkel, C., Wack, C., Dersch, R., Rudisile, M., et al. Influence of poly(L-lactic acid) nanofibers and BMP-2-containing poly(L-lactic acid) nanofibers on growth and osteogenic differentiation of human mesenchymal stem cells. ScientificWorldJournal 8, 1269, 2008.
40. Beresford, J.N., Joyner, C.J., Devlin, C., and Triffitt, J.T. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 39, 941, 1994.
41. Soung, D.Y., Gentile, M.A., Duong, L.T., and Drissi, H. Effects of pharmacological inhibition of cathepsin K on fracture repair in mice. Bone 55, 248, 2013.
42. Arthur, A., Panagopoulos, R.A., Cooper, L., Menicanin, D., Parkinson, I.H., Codrington, J.D., et al. EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair. J Bone Miner Res 28, 926, 2013.
43. Spiro, A.S., Khadem, S., Jeschke, A., Marshall, R.P., Pogoda, P., Ignatius, A., et al. The SERM raloxifene improves diaphyseal fracture healing in mice. J Bone Miner Metab 31, 629, 2013.
44. Gadeau, A.P., Chaulet, H., Daret, D., Kockx, M., Daniel-Lamaziere, J.M., and Desgranges, C. Time course of osteopontin, osteocalcin, and osteonectin accumulation and calcification after acute vessel wall injury. J Histochem Cytochem 49, 79, 2001.
45. Hosseinkhani, H., Hosseinkhani, M., Khademhosseini, A., and Kobayashi, H. Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J Control Release 117, 380, 2007.
46. Owen, T.A., Aronow, M., Shalhoub, V., Barone, L.M., Wilming, L., Tassinari, M.S., et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143, 420, 1990.
47. Desbois, C., and Karsenty, G. Osteocalcin cluster: implications for functional studies. J Cell Biochem 57, 379, 1995.
48. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747, 1997.
49. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755, 1997.
50. Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C., Rosewell, I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765, 1997.
51. Maruyama, Z., Yoshida, C.A., Furuichi, T., Amizuka, N., Ito, M., Fukuyama, R., et al. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev Dyn 236, 1876, 2007.
52. Chevallier, N., Anagnostou, F., Zilber, S., Bodivit, G., Maurin, S., Barrault, A., et al. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 31, 270, 2010.
53. Kim, H.J., Kim, J.H., Bae, S.C., Choi, J.Y., and Ryoo, H.M. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278, 319, 2003.
54. Xiao, G., Jiang, D., Gopalakrishnan, R., and Franceschi, R.T. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277, 36181, 2002.
55. Javed, A., Bae, J.S., Afzal, F., Gutierrez, S., Pratap, J., Zaidi, S.K., et al. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 283, 8412, 2008.
56. Debiais, F., Hott, M., Graulet, A.M., and Marie, P.J. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res 13, 645, 1998.
57. Yamamoto, M., Takahashi, Y., and Tabata, Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24, 4375, 2003.
58. Yamamoto, M., Takahashi, Y., and Tabata, Y. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 12, 1305, 2006.
59. Tabata, Y., Hijikata, S., Muniruzzaman, M., and Ikada, Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 10, 79, 1999.
60. Kusuhara, H., Itani, Y., Isogai, N., and Tabata, Y. Randomized controlled trial of the application of topical b-FGFimpregnated gelatin microspheres to improve tissue survival in subzone II fingertip amputations. J Hand Surg Eur 36, 455, 2011.
61. Takagi, G., Miyamoto, M., Tara, S., Takagi, I., Takano, H., Yasutake, M., et al. Controlled-release basic fibroblast growth factor for peripheral artery disease: comparison with autologous bone marrow-derived stem cell transfer. Tissue Eng Part, A 17, 2787, 2011.
62. Nunamaker, D.M. Experimental models of fracture repair. Clin Orthop Relat Res 355 Suppl, S56, 1998.
63. Ashhurst, D.E., Hogg, J., and Perren, S.M. A method for making reproducible experimental fractures of the rabbit tibia. Injury 14, 236, 1982.
64. Cheal, E.J., Mansmann, K.A., DiGioia, A.M., 3rd, Hayes, W.C., and Perren, S.M. Role of interfragmentary strain in fracture healing: ovine model of a healing osteotomy. J Orthop Res 9, 131, 1991.
65. Hiltunen, A., Vuorio, E., and Aro, H.T. A standardized experimental fracture in the mouse tibia. J Orthop Res 11, 305, 1993.
66. Manigrasso, M.B., and O'Connor, J.P. Characterization of a closed femur fracture model in mice. J Orthop Trauma 18, 687, 2004.
67. Garcia, P., Holstein, J.H., Histing, T., Burkhardt, M., Culemann, U., Pizanis, A., et al. A new technique for internal fixation of femoral fractures in mice: impact of stability on fracture healing. J Biomech 41, 1689, 2008.
68. Garcia, P., Holstein, J.H., Maier, S., Schaumloffel, H., Al-Marrawi, F., Hannig, M., et al. Development of a reliable non-union model in mice. J Surg Res 147, 84, 2008.
69. Holstein, J.H., Menger, M.D., Scheuer, C., Meier, C., Culemann, U., Wirbel, R.J., et al. Erythropoietin (EPO): EPOreceptor signaling improves early endochondral ossification and mechanical strength in fracture healing. Life Sci 80, 893, 2007.
70. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F.V., Jr., Ferrara, N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99, 9656, 2002.
71. Yang, X., Ricciardi, B.F., Hernandez-Soria, A., Shi, Y., Pleshko Camacho, N., and Bostrom, M.P. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41, 928, 2007.
72. Duvall, C.L., Taylor, W.R., Weiss, D., Wojtowicz, A.M., and Guldberg, R.E. Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J Bone Miner Res 22, 286, 2007.
73. Uusitalo, H., Hiltunen, A., Soderstrom, M., Aro, H.T., and Vuorio, E. Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif Tissue Int 67, 382, 2000.